Marine Derived Hamacanthins as Lead for the Development of Novel PDGFRβ Protein Kinase Inhibitors
AbstractIn this study, we report on pyrazin-2(1H)-ones as lead for the development of potent adenosine triphosphate (ATP) competitive protein kinase inhibitors with implications as anti-cancer drugs. Initially, we identified the pyrazin-2(1H)-one scaffold from hamacanthins (deep sea marine sponge alkaloids) by Molecular Modeling studies as core binding motif in the ATP pocket of receptor tyrosine kinases (RTK), which are validated drug targets for the treatment of various neoplastic diseases. Structure-based design studies on a human RTK member PDGFR (platelet-derived growth factor receptor) suggested a straight forward lead optimization strategy. Accordingly, we focused on a Medicinal Chemistry project to develop pyrazin-2(1H)-ones as optimized PDGFR binders. In order to reveal Structure-Activity-Relationships (SAR), we established a flexible synthetic route via microwave mediated ring closure to asymmetric 3,5-substituted pyrazin-2(1H)-ones and produced a set of novel compounds. Herein, we identified highly potent PDGFR binders with IC50 values in an enzymatic assay below µM range, and possessing significant activity against PDGFR dependent cancer cells. Thus, marine hamacanthin-derived pyrazin-2(1H)-ones showing interesting properties as lead for their further development towards potent PDGFR-inhibitors.
- Supplementary File 1:
- Supplementary File 2:
- Supplementary File 3:
- Supplementary File 4:
- Supplementary File 5:
- Supplementary File 6:
- Supplementary File 7:
- Supplementary File 8:
- Supplementary File 9:
- Supplementary File 10:
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Pinchuk, B.; Johannes, E.; Gul, S.; Schlosser, J.; Schaechtele, C.; Totzke, F.; Peifer, C. Marine Derived Hamacanthins as Lead for the Development of Novel PDGFRβ Protein Kinase Inhibitors. Mar. Drugs 2013, 11, 3209-3223.
Pinchuk B, Johannes E, Gul S, Schlosser J, Schaechtele C, Totzke F, Peifer C. Marine Derived Hamacanthins as Lead for the Development of Novel PDGFRβ Protein Kinase Inhibitors. Marine Drugs. 2013; 11(9):3209-3223.Chicago/Turabian Style
Pinchuk, Boris; Johannes, Eugen; Gul, Sheraz; Schlosser, Joachim; Schaechtele, Christoph; Totzke, Frank; Peifer, Christian. 2013. "Marine Derived Hamacanthins as Lead for the Development of Novel PDGFRβ Protein Kinase Inhibitors." Mar. Drugs 11, no. 9: 3209-3223.